U.S. FDA Reviewer: review clinical data and clinical trial design for all stages of drug development (IND/NDA/BLA, Phase I-IV).
Ph.D. Scientist in Biology. Also an expert in Structural Biology, Clinical Pharmacology and Clinical Trials.
EMBA with Well trained business mindset, and corporate finance trainings.
Alumni @National Cancer Institute, EMBA@Quantic School of Business and Technology, Ph.D.@Virginia Tech, B.S.@Nankai University
Invited by: 村长
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
September 13, 2023 | 245 | -1 | -0.5% |
October 29, 2022 | 246 | +1 | +0.5% |
January 29, 2022 | 245 | +1 | +0.5% |
December 23, 2021 | 244 | +2 | +0.9% |
November 15, 2021 | 242 | +2 | +0.9% |
October 07, 2021 | 240 | +1 | +0.5% |
August 25, 2021 | 239 | +40 | +20.2% |